Nestle Develops New Products for Weight-Loss Drug Users

By admin August 17, 2026 No comment

featured News Trending

Nestle is looking to turn the rapid growth of GLP-1 weight-loss drugs into a new business opportunity by developing products specifically for people taking medicines such as Ozempic and Wegovy. The company is using artificial intelligence and nutritional science to study the effects of rapid weight loss and identify products that could support users’ nutritional […]

Lower Prices for Branded Weight-Loss Pills Drive Patients Away from Compounded Alternatives

By admin May 21, 2026 No comment

featured News Trending

Lower pricing structures for oral weight-loss medications from Novo Nordisk and Eli Lilly are increasingly motivating patients to transition away from compounded drugs toward authentic branded options. Historically, the rampant shortages of branded injectable obesity treatments allowed compounding pharmacies to flourish by mixing their own personalized formulations.

Novo Nordisk Loses Wegovy-Era Gains

By admin February 24, 2026 No comment

featured News Trending

Shares of Novo Nordisk plunged more than 16%, erasing the remaining gains driven by its blockbuster weight-loss drug Wegovy. The sharp decline followed disappointing trial results for its next-generation obesity treatment CagriSema, which underperformed a rival therapy from Eli Lilly. The drop pushed Novo’s valuation sharply lower, extending a massive fall from its 2024

Novo’s Wegovy Weight-Loss Pill Shows Strong Early Momentum Against Lilly

By admin January 17, 2026 No comment

featured News Trending

Novo Nordisk’s newly launched Wegovy weight-loss pill has shown encouraging early uptake in the United States, according to analysts citing initial prescription data. About 3,071 retail prescriptions were filled in the first four days after the January 5 launch, offering a first glimpse of performance for the first oral GLP-1 weight-loss drug to reach the […]